Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2007
02/20/2007US7179963 Maize CLAVATA3-like polynucleotide sequences and methods of use
02/20/2007US7179962 Protein kinase stress-related proteins and methods of use in plants
02/20/2007US7179961 Transforming plant tissues having germ cells with nucleotide sequences, then culturing and harvesting the grains such that the cells have increased biomass; genetic engineering
02/20/2007US7179960 Expression vector coding prunin (PRU) protein for transformation and generation of plants and seed with enhanced storage capacity
02/20/2007US7179955 Comprises nucleotide sequences coding lyase for modification of polysaccharide concentration in cells of plants
02/20/2007US7179954 Nucleic acids obtainable through complementing nuclear base transporter-deficient host cells with a plant or animal gene bank
02/20/2007US7179953 Monitoring APP cleavage in transgenic rodents comprising an APP-Swedish mutation
02/20/2007US7179903 Liver specific transcriptional enhancer
02/20/2007US7179901 Renal regulatory elements and methods of use thereof
02/20/2007US7179898 Human vanilloid receptor-like receptor
02/20/2007US7179895 Rat calcium channel subunits and related probes, cell lines and methods
02/20/2007US7179893 Recombinant anti-TNF-α antibodies
02/20/2007US7179891 A proteinaceous part having TNF activity and a high molecular polyethylene part bound artificially to the N-terminus of the proteinaceous part, with higher stability; antitumor agents
02/20/2007US7179890 Polypeptides as angiogenesis inhibitors
02/20/2007US7179889 Propionicin T1 polypeptide, a bacteriocin from Propionibacterium thoenii
02/20/2007US7179888 Antigenic, non-toxic mutants of Clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith
02/20/2007US7179887 Protein with a molecular weight of between 41 55 kD; useful for the development of models of human platelet aggregation
02/20/2007US7179885 For photographic uses
02/20/2007US7179884 Polypeptides; proteolysis splitting; antitumor agents
02/20/2007US7179795 Nucleic acids encoding chimeric proteins comprising BMP-2 and a proteinase inhibitor
02/20/2007US7179790 Brain natriuretic peptide
02/20/2007US7179787 Methods of using human Zven proteins
02/20/2007US7179786 Variants of the NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and their use
02/20/2007US7179784 Surfactant peptide nanostructures, and uses thereof
02/20/2007US7179650 Providing, in vitro, the cell with a nucleic acid segment encoding a polypeptide comprising wherein a Fas and/or TNFR1 mediated apoptosis pathway is inhibited in the cell
02/20/2007US7179645 Hybrid polypeptide; induce immunology response, antiallergens; major histocompatibility complex; vaccine
02/20/2007US7179640 For detecting early conception factor in a body fluid from an animal comprising the antibodies which specifically bind early conception factor
02/20/2007US7179634 Methods for producing a polypeptide in a Bacillus cell
02/20/2007US7179631 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
02/20/2007US7179622 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs
02/20/2007US7179621 Pigment epithelium-derived factor: sequence of the PEDF gene
02/20/2007US7179620 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis of vision defects
02/20/2007US7179618 Streptavidin proteins
02/20/2007US7179617 Forming a convalent conjugate of a Factor IX peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety
02/20/2007US7179610 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state
02/20/2007US7179608 Therapeutic antiangiogenic compositions and methods
02/20/2007US7179606 Utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state
02/20/2007US7179605 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state
02/20/2007US7179604 Methods of use of DNA encoding a human histamine receptor of the H3 subtype
02/20/2007US7179601 Methods of identifying plant disease-resistance genes
02/20/2007US7179588 Assay for the detection of paclitaxel resistant cells in human tumors
02/20/2007US7179473 Attenuated pestiviruses
02/20/2007US7179472 Circovirus sequences associated with piglet weight loss disease (PWD)
02/20/2007US7179471 Materials and methods relating to fusion proteins an immune response
02/20/2007US7179470 Hepatitis-C virus testing
02/20/2007US7179467 DCMP2 polypeptide
02/20/2007US7179466 Methods of treating rheumatoid arthritis by multiple administration of anti-TNF antibodies
02/20/2007US7179465 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type 1 interferon
02/20/2007US7179464 Immunoglobulin for use in the treatment and prevention of asthma
02/20/2007US7179463 Treatment of alzheimer's disease
02/20/2007US7179462 α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof
02/20/2007US7179458 Lactobacilli expressing biologically active polypeptides and uses thereof
02/20/2007US7179457 Modified to include heterologous insertion downstream of its replicase open reading frames; insertion preferably comprises one or more protein-coding regions ideal for virus-like particles packaging
02/20/2007US7179448 Recombinant constructs of Borrelia burgdorferi
02/20/2007CA2346997C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto
02/20/2007CA2309312C The process for preparing octreotide and derivatives thereof
02/20/2007CA2230975C Wheat aleurone promoter
02/20/2007CA2218499C Chemokine binding protein and methods of use therefor
02/20/2007CA2193210C Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen
02/20/2007CA2175628C Production of recombinant factor viii in the presence of liposome-like substances of mixed composition
02/19/2007CA2516742A1 Botulinum toxin in treatment of clubfoot
02/15/2007WO2007019545A2 Tissue protective peptides and uses thereof
02/15/2007WO2007019442A2 Polypeptides having beta-glucosidase activity and polynucleotides encoding same
02/15/2007WO2007019427A2 Methods and compositions for preserving the viability of photoreceptor cells
02/15/2007WO2007019426A2 A novel peptide involved in energy homeostasis
02/15/2007WO2007019421A2 Regulation of of s6 kinase protein activity and related methods
02/15/2007WO2007019411A2 Peptides for diagnostic and therapeutic methods for celiac sprue
02/15/2007WO2007019382A1 Photoactivatable chromo/fluorescent gfp-like proteins and imaging applications
02/15/2007WO2007019331A2 Conjugates of a g-csf moiety and a polymer
02/15/2007WO2007019267A1 MODULATING THE KV1.1 VOLTAGE-GATED POTASSIUM CHANNEL IN T-CELLS FOR REGULATING THE SYNTHESIS AND SECRETION OF TUMOR NECROSIS FACTOR α (TNF-α) AND TREATING HUMAN DISEASES OR INJURIES MEDIATED BY DETRIMENTALLY HIGH OR LOW LEVELS OF TNF-α
02/15/2007WO2007019266A2 Killing human lymphoma and leukemia cancer cells and tcr-activated normal human cells by dopamine d1r agonists
02/15/2007WO2007019223A1 Suppression of b-cell apoptosis in transgenic animals expressing humanized immunoglobulin
02/15/2007WO2007019094A2 Modified influenza virus for monitoring and improving vaccine efficiency
02/15/2007WO2007018879A2 Interferon-gamma antagonists and therapeutic uses thereof
02/15/2007WO2007018843A2 Methods and compositions for diagnosis and treatment of influenza
02/15/2007WO2007018759A2 Ligand-binding reagents for quenching and improved purification of lipidated proteins
02/15/2007WO2007018671A2 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
02/15/2007WO2007018585A2 Process for controlling protein to salt ratio in animal muscle protein composition and protein composition
02/15/2007WO2007018475A1 Novel anticoagulant polypeptides and complex
02/15/2007WO2007018463A2 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
02/15/2007WO2007018442A2 Expression of an active carrier for xylose in genetically modified saccharomyces cerevisiae
02/15/2007WO2007018335A1 Transferrin receptor imaging agent and preparation method thereof
02/15/2007WO2007018315A1 Protein probe for use in detection of interaction between the protein and other molecule
02/15/2007WO2007018307A1 Phosphoadenylyl sulfate reductase gene and use thereof
02/15/2007WO2007018049A1 Antigen capable of inducing neutralizing antibody for high risk-type human papillomavirus
02/15/2007WO2007018047A1 Squamous cell carcinoma antigen-derived peptide binding to hla-a24 molecule
02/15/2007WO2007017907A2 A novel nucleic acid encoding a novel protein of candida albicans and uses thereof
02/15/2007WO2007017671A1 Collagen peptides, methods and uses
02/15/2007WO2007017637A1 Method for producing recombinant interferon alpha-8
02/15/2007WO2007017635A1 Immunogenic constructs
02/15/2007WO2007017419A2 Method for producing arachidonic acid and/or eicosapentaenoic acid in useful transgenic plants
02/15/2007WO2007017277A1 METHOD FOR THE PURIFICATION OF ALPHA-1 PROTEINASE INHIBITOR (a1PI)
02/15/2007WO2007017201A1 Generation of antigen specific t cells
02/15/2007WO2007017067A2 Modulators of the melted protein and uses thereof
02/15/2007WO2007016938A2 Methods for diagnosing colon cancer and streptococcus bovis proteins for use in the method
02/15/2007WO2007016777A1 Targeted protein kinase c inhibitors and uses thereof
02/15/2007WO2007016763A1 Peptides targeted to protein kinase c isoforms and uses thereof
02/15/2007WO2006138567A3 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
02/15/2007WO2006138509A3 Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis
02/15/2007WO2006136831A3 Gene expression technique